ArticleArchives of endocrinology and metabolism2026
Differences in the aggressiveness of familial versus sporadic non-medullary thyroid cancer: An unresolved controversy.
Article in Archives of endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveFamilial non-medullary thyroid cancer (FNMTC) is defined as non-medullary thyroid cancer occurring in two or more first-degree relatives, without features of known hereditary syndromes. Although familial predisposition is well established, its clinical behavior remains debated. This study aimed at characterizing familial cases compared to sporadic non-medullary thyroid cancer (SNMTC). SUBJECTS AND
methodsFNMTC and SNMTC patients were recruited from the Endocrine Division (SEMPR) of the Federal University of Paraná, Brazil, and private endocrine clinics in Curitiba, Paraná, Brazil (2000-2019). Baseline, histopathological, and clinical data were analyzed using SPSS Statistics 26.0. Statistical comparisons employed chi-square, Student's t test, and Mann-Whitney U test, as appropriate. Post hoc power analysis was performed using G*Power 3.1.9.7, and R 2025.05.0.
resultsWe analyzed 39 FNMTC and 119 SNMTC patients. Papillary thyroid carcinoma was the predominant histological type in both groups. FNMTC patients were diagnosed at a younger age (38.5 ± 14.2 vs. 46.6 ± 13.8 years, p = 0.003) and more frequently presented with lymph node metastases at diagnosis (46.2% vs. 21.8%, p = 0.007), with a 4.57-fold increased risk. Despite these differences, long-term outcomes did not differ significantly between groups. An earlier disease onset in subsequent generation suggests a possible anticipation phenomenon.
conclusionThese findings suggest that FNMTC patients may present with earlier onset and higher rates of lymph node involvement, underscoring the need for thorough preoperative lateral neck evaluation. In view of a possible anticipation phenomenon, cervical ultrasound screening might be considered starting in adolescence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.